Jose Abrigo, Esq., HIV Project Director of the Lambda Legal Defense and Education Fund, explains the biggest HIV issues anticipated this year.
Aside from the pending FDA approval of injectable lenacapavir as a form of pre-exposure prophylaxis, Jose Abrigo, Esq., HIV Project Director of the Lambda Legal Defense and Education Fund says to expect HIV program defunding under the Trump Administration as well as updates to the Braidwood v. Becerra case, a lawsuit threatening PrEP-specific coverage requirements under the Affordable Care Act.
“The big agencies that set that help set, guide and put forward policies and furtherance of HIV prevention and HIV care, like the FDA, like the CDC, their funding is likely going to be cut,” Abrigo said in an interview with Managed Healthcare Executive.
HIV + Hepatitis Institute Welcomes RFK, Talks Importance of Ending the HIV Epidemic
February 13th 2025The group released a statement today expressing that they are eager to work with Robert F. Kennedy Jr. to eradicate HIV when steps into his role as the Secretary of Health and Human Services.
Read More
Trump Administration Throws U.S. AIDS Support into Turmoil
February 6th 2025PEPFAR, the main U.S.-funded global AIDS program was given a waiver from the foreign aid freeze, but there is still uncertainty and interruptions, partly because many PEPFAR programs are implemented through USAID, which has been largely shutdown by the news administration.
Read More
RFK Jr. and HIV Denial: He Says He Is Neutral, But...
January 29th 2025In 2021 book attacking Anthony Fauci, M.D., Robert F. Kennedy Jr. casts doubt on HIV being the sole cause of AIDS and presents arguments made by "HIV deniers" that believe it is bystander in the immunosuppression that characterizes AIDS.
Read More